AZLI
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Gilead Sciences
Overview
AZLI is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
AZLI clinical trials
Explore related
Medical disclaimer. This page summarizes research about AZLI for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.